VYNE Therapeutics Inc.
VYNE
$0.37
-$0.01-3.57%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -21.14% | -18.28% | -12.35% | -10.14% | -9.13% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 1.19% | 58.88% | -11.57% | -41.32% | 33.42% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | 2.17% | -14.81% |
Total Current Assets | -19.25% | -14.78% | -12.37% | -12.22% | -7.15% |
|
|||||
Total Current Assets | -19.25% | -14.78% | -12.37% | -12.22% | -7.15% |
Net Property, Plant & Equipment | -20.71% | -17.96% | 68.85% | -19.21% | -16.11% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -82.03% | -40.72% | -10.98% | -6.62% | 113.75% |
Total Assets | -20.75% | -15.67% | -12.20% | -12.06% | -5.48% |
|
|||||
Total Accounts Payable | -59.99% | 30.55% | -32.09% | -11.74% | 61.57% |
Total Accrued Expenses | -16.74% | -38.54% | 18.70% | 95.38% | 128.99% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -60.32% | -36.36% | -19.51% | 2.50% | 2.56% |
Total Finance Division Other Current Liabilities | -- | -0.20% | 160.47% | -61.53% | 42.21% |
Total Other Current Liabilities | -- | -0.20% | 160.47% | -61.53% | 42.21% |
Total Current Liabilities | -52.52% | -17.06% | 17.04% | 7.72% | 69.61% |
|
|||||
Total Current Liabilities | -52.52% | -17.06% | 17.04% | 7.72% | 69.61% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -60.32% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -52.52% | -17.06% | 17.04% | 7.49% | 41.81% |
|
|||||
Common Stock & APIC | 0.06% | 0.09% | 0.07% | 0.09% | 0.11% |
Retained Earnings | -0.78% | -1.18% | -1.67% | -1.72% | -1.35% |
Treasury Stock & Other | -- | -- | -41.18% | 158.62% | 17.14% |
Total Common Equity | -11.90% | -15.27% | -18.02% | -15.14% | -10.20% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -11.90% | -15.27% | -18.02% | -15.14% | -10.20% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -11.90% | -15.27% | -18.02% | -15.14% | -10.20% |
|